Identification Generic Name (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid DrugBank Accession Number DB03455 Background (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is a solid. This compound belongs to the indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2. 
 Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid (DB03455) ×  Close Weight Average: 266.316  Monoisotopic: 266.072513014  Chemical Formula C 12 H 14 N 2 O 3 S Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Interleukin-2 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Indoles and derivatives Sub Class Indolyl carboxylic acids and derivatives Direct Parent Indole-3-acetic acid derivatives Alternative Parents Alpha amino acids and derivatives  /  3-alkylindoles  /  Substituted pyrroles  /  Benzenoids  /  Heteroaromatic compounds  /  N-organohydroxylamines  /  Monocarboxylic acids and derivatives  /  Carboxylic acids  /  Azacyclic compounds  /  Alkylthiols  /  Organopnictogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 4 more Substituents 3-alkylindole  /  Alkylthiol  /  Alpha-amino acid or derivatives  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Carbonyl group  /  Carboxylic acid  /  Carboxylic acid derivative  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Indole  /  Indole-3-acetic acid derivative  /  Monocarboxylic acid or derivatives  /  N-organohydroxylamine  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Organosulfur compound  /  Pyrrole  /  Substituted pyrrole 
 
 
  show 14 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key FJAWIBGKKKXXAL-LLVKDONJSA-N InChI InChI=1S/C12H14N2O3S/c15-12(16)11(14-17-5-6-18)9-7-13-10-4-2-1-3-8(9)10/h1-4,7,11,13-14,18H,5-6H2,(H,15,16)/t11-/m1/s1 IUPAC Name (2R)-2-(1H-indol-3-yl)-2-[(2-sulfanylethoxy)amino]acetic acid SMILES [H][C@](NOCCS)(C(O)=O)C1=CNC2=C1C=CC=C2 References General References Not Available External Links PubChem Compound 447066 PubChem Substance 46507395 ChemSpider 394263 ZINC ZINC000005889662 PDBe Ligand MPE PDB Entries 1m4a Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.106 mg/mL ALOGPS logP 1.27 ALOGPS logP 1.55 Chemaxon logS -3.4 ALOGPS pKa (Strongest Acidic) 4.29 Chemaxon pKa (Strongest Basic) 2.44 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 74.35 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 80.66 m 3 ·mol -1 Chemaxon Polarizability 27.27 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9923 Blood Brain Barrier + 0.8273 Caco-2 permeable - 0.6411 P-glycoprotein substrate Non-substrate 0.6219 P-glycoprotein inhibitor I Non-inhibitor 0.9422 P-glycoprotein inhibitor II Non-inhibitor 0.9935 Renal organic cation transporter Non-inhibitor 0.8536 CYP450 2C9 substrate Non-substrate 0.8554 CYP450 2D6 substrate Non-substrate 0.7844 CYP450 3A4 substrate Non-substrate 0.724 CYP450 1A2 substrate Non-inhibitor 0.5429 CYP450 2C9 inhibitor Non-inhibitor 0.7117 CYP450 2D6 inhibitor Non-inhibitor 0.8421 CYP450 2C19 inhibitor Non-inhibitor 0.7303 CYP450 3A4 inhibitor Non-inhibitor 0.6723 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.718 Ames test Non AMES toxic 0.5222 Carcinogenicity Non-carcinogens 0.8846 Biodegradation Not ready biodegradable 0.9351 Rat acute toxicity 2.2816 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9489 hERG inhibition (predictor II) Non-inhibitor 0.7608    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Interleukin-2 Kind Protein Organism Humans Pharmacological action Unknown General Function Kinase activator activity Specific Function Produced by T-cells in response to antigenic or mitogenic stimulation, this protein is required for T-cell proliferation and other activities crucial to regulation of the immune response. Can stimu... Gene Name IL2 Uniprot ID P60568 Uniprot Name Interleukin-2 Molecular Weight 17627.52 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 